Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • Lefradafiban - Healthy
    Clinical Study Number 509.118
    Study Indication Healthy
    Product Lefradafiban
    Generic Name Lefradafiban
    Lab Code
    Clinical Phase I
    Study Title

    Influence of 40 mg Pantoprazole per day on the pharmacokinetics of Fradafiban after multiple oral doses of 30 mg Lefradafiban tid as acid free tablet and sachet over 5 days in healthy subjects. A 4-way crossover randomized open trial.

    Study Document
    Trial synopsis 509.118 english
  • Lefradafiban - Healthy
    Clinical Study Number 509.119
    Study Indication Healthy
    Product Lefradafiban
    Generic Name Lefradafiban
    Lab Code
    Clinical Phase I
    Study Title

    Influence of 40 mg Pantoprazole per day on the pharmacokinetics of Fradafiban after multiple oral doses of 30 mg Lefradafiban tid as acid free tablet and sachet over 5 days in healthy subjects. A 4-way crossover randomized open trial.

    Study Document
    Trial synopsis 509.119 english
  • Lefradafiban - Healthy
    Clinical Study Number 509.302
    Study Indication Healthy
    Product Lefradafiban
    Generic Name Lefradafiban
    Lab Code
    Clinical Phase I
    Study Title

    Influence of oral doses of 75 mg Clopidogrel on the pharmacodynamics and safety of Fradafiban after oral doses of 30 mg Lefradafiban tid over 8 days in healthy male subjects. An intra-individual, open trial.

    Study Document
    Trial synopsis 509.302_CO english